Alnylam Pharmaceuticals I...

NASDAQ: ALNY · Real-Time Price · USD
449.02
6.29 (1.42%)
At close: Aug 15, 2025, 3:59 PM
448.00
-0.23%
After-hours: Aug 15, 2025, 05:30 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-107.99 -54.31 -25.57 -23.55
PEG Ratio
2.79 0.87 -0.88 6.76
PS Ratio
13.36 13.08 27.88 23.79
PB Ratio
447.73 -108.36 -182.78 34.15
P/FCF Ratio
-705.29 569.99 -47.15 -27.97
P/OCF Ratio
-3.61K 229.54 -53.43 -31.3
OCF/S Ratio
-0.00 0.06 -0.52 -0.76
Debt / Equity Ratio
19.32 -5.92 -8.34 1.70
Quick Ratio
2.71 2.99 3.34 3.91
Current Ratio
2.78 3.08 3.51 4.04
Asset Turnover
0.53 0.48 0.29 0.23
Interest Coverage
-1.25 -2.33 -5.03 -4.95
Return on Equity
-4.15 2.00 7.15 -1.45
Return on Assets
-0.07 -0.11 -0.32 -0.23
Return on Invested Capital
-0.04 -0.1 -0.28 -0.24
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.86 0.83 0.84 0.83
Net Profit Margin
-0.12 -0.24 -1.09 -1.01
Pretax Profit Margin
-0.17 -0.24 -1.09 -1.01
Operating Profit Margin
-0.08 -0.15 -0.76 -0.84
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.08 -0.14 -0.89 -0.78